13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DISETRONIC RAPID SUBCUTANEOUS INFUSION SET AND DISTERONIC RAPID D SUBCUTANEOUS INFUSION SET

FDA 510(k)
FDA Class 2 ·General Hospital

Custom Procedure Kit

FDA UDI
MEDIVATORS INC.·40677964025127·The ENDO CARRY-ON Procedure Kit contains all of...

LINK Instruments - Rasps, compressors and broaches

FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575293513·Orthopaedic prosthesis instrument, reusable - G...

COMPONENTS FOR CARDIOVASCULAR PROCEDURE KIT - HEAT EXCHANGER COILS

FDA 510(k)
FDA Class 2 ·Cardiovascular

SMARTSCREW MODEL 222006...227510

FDA 510(k)
FDA Class 2 ·Orthopedic

REVERSE SHOULDER SYSTEM HUMERAL REVERSE HC LINER Ø39/+6MM

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code PHX·June 14, 2022

WALLFLEX¿ BILIARY

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - GALWAY·Product code FGE·March 14, 2013

UROLOGICAL BALLOON DILATATION CATHETER

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - GALWAY·Product code EZN·March 1, 2011

PROCEED

FDA Adverse Event
Injury ·ETHICON·Product code FTL·February 25, 2008

FISHER & PAYKEL HEALTHCARE

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE LTD·Product code BTT·January 15, 2026

bk5000 Ultrasound System w/battery; Model No. 2300-61; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024